CAVERJECT

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Ireland, Malta, Mexico, New Zealand, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug CAVERJECT contains one active pharmaceutical ingredient (API):

1 Alprostadil UNII F5TD010360 - ALPROSTADIL

Alprostadil is chemically identical to prostaglandin E1, the actions of which include vasodilatation of blood vessels in the erectile tissues of the corpora cavernosa and increase in cavernosal artery blood flow, causing penile rigidity. Read about Alprostadil

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CAVERJECT Powder for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
G04BE01	Alprostadil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4579B, 4580C
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720030084107, 522720030084207
Country: CA	Health Products and Food Branch	Identifier(s): 02215187, 02215756
Country: EE	Ravimiamet	Identifier(s): 1021925, 1023769, 1700817, 1705979, 1708365, 1708376, 1717343, 1717354, 1723890, 1730326, 1798948, 1810976, 1813834, 1813845, 1816781, 1872558
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 60535, 60911
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 000552, 000784
Country: FR	Base de données publique des médicaments	Identifier(s): 65613168, 68594342
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 34520, 37144, 37151, 38573, 38597
Country: HK	Department of Health Drug Office	Identifier(s): 50155
Country: IE	Health Products Regulatory Authority	Identifier(s): 16886, 76760
Country: MT	Medicines Authority	Identifier(s): AA505/07902
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 332M95
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15633, 15634
Country: SG	Health Sciences Authority	Identifier(s): 08097P, 08718P
Country: US	FDA, National Drug Code	Identifier(s): 0009-3701, 0009-5181, 0009-5182, 0009-7686, 63539-121, 63539-221
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/7.1/0329